Results
1 -
5 of
5Novel Drugs Targeting the Epigenome, Current Pharmacology Reports The BET bromodomain inhibitor apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation, Acta Pharmacologica Sinica Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208), Journal of Cardiovascular Translational Research Selective BET Protein Inhibition with Apabetalone and Cardiovascular Events: A Pooled Analysis of Trials in Patients with Coronary Artery Disease, American Journal of Cardiovascular Drugs J. Truong, A. George, J. K. Holien.
10